Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Elife|April 21, 2017
Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human <i>ALK</i> mutant neuroblastoma cell lines and xenograft modelsHui Qin Wang, Ensar Halilovic, Xiaoyan Li, et al.Acta Pharmacologica Sinica|March 7, 2025
Ginsenoside Rg1 alleviates chronic stress-induced depression in rats by targeting Cx43-YAP axisHui-Qin Wang, Rui-Fang Zheng, Qi-di Ai, et al.Archives of Medical Science : AMS|June 17, 2026
The effect of beinaglutide on visceral fat and body weight in obese type 2 diabetic patientsGui-Ying Wang, Hui-Qin Wang, Feng-Juan Zhang, et al.European Journal of Pharmacology|January 11, 2025
The pathogenesis of depression: Roles of connexin 43-based gap junctions and inflammationHong Jiang, Meng Zhang, Xin-Mu Li, et al.Cancer Research|January 28, 2021
Inhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal MicroenvironmentHui Qin Wang, Iain J Mulford, Fiona Sharp, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2020
LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven TumorsKelli-Ann Monaco, Scott Delach, Jing Yuan, et al.Scientific Reports|July 22, 2021
PAX8 lineage-driven T cell engaging antibody for the treatment of high-grade serous ovarian cancerEmily Lee, Sarah Szvetecz, Ryan Polli, et al.Nature Medicine|March 6, 2018
SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitorsLeila Dardaei, Hui Qin Wang, Manrose Singh, et al.Nature Medicine|October 20, 2015
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug responseHui Gao, Joshua M Korn, Stéphane Ferretti, et al.Pageof 5